Current News and Highlights for Animal Health
NMPF Responds to FDA Request for Feedback on On-Farm Antimicrobial Use and Resistance Data Collection
On Nov. 30, NMPF submitted comments on an FDA request for input on potential on-farm antimicrobial use and resistance data collection. NMPF commended the efforts of the FDA, USDA and CDC to request feedback on the best approaches for data collection on these issues.
NMPF commented that the relationship between antibiotic use and resistance is highly complex and that associated data has strong potential to be misinterpreted to portray responsible husbandry practices as harmful. Compounding this challenge is the reality that collecting meaningful representative data would be highly resource intensive. NMPF also expressed concerns that collecting on-farm antimicrobial use data without first outlining science-based goals and objectives may lead to less robust and less useful results.
NMPF Submits Comments on the Eligibility of Namibia to Export Meat Products to the U.S.
The U.S. Department of Agriculture Food Safety Inspection Service (USDA FSIS) issued a proposed rule that, if implemented, would allow the importation of beef and beef products from Namibia.
In its comments submitted Nov. 17, NMPF supported the USDA FSIS equivalency process, but strongly opposed opening the United States to imports of meat from Namibia because the USDA Animal and Plant Health Inspection Service (APHIS) had not conducted a review of the disease status of Namibia and therefore not published a formal risk assessment for comment. Its concern is based on the 29 outbreaks of Foot and Mouth Disease (FMD) in cattle Namibia has had as of November 16, 2015.
NMPF Responds to Codex Circular Letter on Antimicrobial Resistance
On Nov. 19, NMPF responded to a request by the Codex Alimentarius Commission (CAC) asking for input on its work in Antimicrobial Resistance (AMR), alongside other adoptions by the World Health Organization of the Global Action Plan to Combat Antimicrobial Resistance and by the Food and Agriculture Organization of the Resolution of Antimicrobial Resistance.
In light of the extensive CODEX and OIE codes on AMR, NMPF submitted comments to the U.S. Codex Office on the Circular Letter opposing new work while the U.S. is currently implementing these international codes.
NMPF Opposes FDA Proposal on Reporting Drugs Sales for Livestock
On Aug. 18, NMPF submitted comments on the FDA proposed regulation for pharmaceutical companies to report drug sales and distribution data for livestock.
Currently, pharmaceutical companies are required by law to report aggregate drug sales and distribution data for livestock by type of drug. FDA proposed that the pharmaceutical companies should report estimates by species (cattle, swine, horse, sheep, goat, poultry). NMPF commented in opposition to this FDA proposal for several reasons, which mainly focus around accuracy of estimations and lack of usefulness of estimate data in context of the larger Federal government initiatives on antimicrobial resistance.
NMPF Opposes USDA-FSIS Proposal on the Disposition of Non-ambulatory Disabled Veal Calves
On Aug. 12, NMPF submitted comments on a USDA-FSIS proposal that would remove the ability for slaughter houses to allow tired or cold animals to have a period of time to rest upon arrival at a slaughter plant; therefore any veal calf which arrives to a slaughter plant which is unable to immediately stand would be considered non-ambulatory, condemned, and immediately euthanized.
NMPF commented in opposition to the USDA FSIS proposal due to the lack of data from USDA-FSIS to justify the change. In fact, USDA-FSIS data indicates the success with which USDA-FSIS inspectors ensure the implementation of the resting period with proper inspection to ensure that non-ambulatory cattle do not enter slaughter.
Resource Center for the Dairy Industry on Animal Health